Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ABEMACICLIB vs ACALABRUTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ABEMACICLIB vs ACALABRUTINIB: Safety Overview

Metric ABEMACICLIB ACALABRUTINIB
Total FAERS Reports 16,389 9,688
Deaths Reported 1,243 2,239
Death Rate 7.6% 23.1%
Hospitalizations 3,635 2,441
Average Patient Age 60.5 yrs 73.2 yrs
% Female Patients 97.4% 36.8%
FDA Approval Date Sep 28, 2017 Aug 3, 2022
Manufacturer Eli Lilly and Company AstraZeneca Pharmaceuticals LP
Route ORAL ORAL
Marketing Status Prescription Prescription